Inside the research

Stryker Corporation

SYK Research profile · latest available data

Price overview

$272.36

▲ +2.61 (+1.0%)

52w hi$385.39
52w lo$269.75
Vol2.34M
As of25 Sep 2026

The Verdict

Hold

Our score -0.19

Short-0.56
Medium-0.10
Long+0.35

computed 2026-09-27

Key fundamentals

Stryker Corporation

Healthcare · Medical Devices

Market cap$104.47B
Enterprise value$116.44B
Trailing P/E28.25x
Forward P/E16.29x
EV / EBITDA15.79x
P / S (ttm)4.04x
Profit margin14.4%
Return on equity16.5%
Revenue growth+9.4%
Earnings growth+44.1%
Debt / equity64.39

Layer Breakdown

LayerRawContribution
Fundamental+0.34
Sector+0.08
Technical-0.37
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

United States · www.stryker.com

Risk Metrics

Beta vs SPX0.57
Corr SPX0.35
Annual vol25.8%
Annual ret-11.3%
Sharpe-0.44
Max DD-33.2%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$392.19
High / Low$465.00 / $315.00
Median$396.03
Analysts26
Strong Buy8
Buy14
Hold7
Sell0
Strong Sell0

Recent rating actions

2026-05-04Truist Securities→ Hold
2026-05-04Barclays→ Overweight
2026-05-01Wells Fargo→ Overweight
2026-05-01Needham→ Buy
2026-05-01JP Morgan→ Overweight
2026-05-01Evercore ISI Group→ Outperform

Officers & Board

CEOKevin A. Lobo since 2012
FounderHomer Stryker current
CEOHomer Stryker current
CEOStephen P. MacMillan 2005–2012
CEOJohn W. Brown 1977–2005
CEOLloyd Lee Stryker 1969–1976

Material Events

DateEvent8-K
2026-07-30Earnings Release, Exhibitsread
2026-06-26Other Material Event, Exhibitsread
2026-05-20Officer / Director Change, Exhibitsread
2026-05-08Shareholder Voteread
2026-04-30Earnings Release, Exhibitsread
2026-03-23Reg FD Disclosure, Exhibitsread
2026-03-12Reg FD Disclosureread
2026-03-11Other Material Eventread
2026-01-29Earnings Release, Exhibitsread
2025-12-04Officer / Director Change, Reg FD Disclosure…read
2025-10-30Earnings Release, Exhibitsread
2025-07-31Earnings Release, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-01King DebraSee RemarksWithheld for tax533$173.60K
2026-08-01Montagnino Kimberly AnnVP, Chief Comm. OfficerWithheld for tax155$50.48K
2026-08-01Fletcher Robert SVP, Chief Legal OfficerWithheld for tax94$30.62K
2026-08-01Fink M KathrynVP, Chief HR OfficerWithheld for tax111$36.15K
2026-06-01Stiles Spencer SPresident and COOGift1.61K—
2026-05-28Fletcher Robert SVP, Chief Legal OfficerSell2.81K$861.14K
2026-05-28Fletcher Robert SVP, Chief Legal OfficerSell165$50.43K
2026-05-28Fletcher Robert SVP, Chief Legal OfficerSell1.07K$327.89K
2026-05-28Fletcher Robert SVP, Chief Legal OfficerSell120$36.51K
2026-05-28Fletcher Robert SVP, Chief Legal OfficerSell258$79.67K

Flow & Concentration

Insider 180d net-$100.66M
Insider buys / sells0 / 14
Insider biasSellers
13F holders9
Top-5 share98.7%
HHI5,940 (concentrated)

Top Holders

HolderValueShares
State Street Corp$4.90B15.53M
Capital Research / Capital World$610.22M1.94M
Fidelity / FMR LLC$535.98M1.70M
Citadel Advisors$174.76M555.06K
AQR Capital Management$149.76M476.10K
Millennium Management$45.61M144.87K
Renaissance Technologies$28.74M91.30K
Bridgewater Associates$3.83M12.15K
T. Rowe Price Group$3.75M11.92M

As of 2026-06-30

Dividends

Yield (TTM)0.95%
$ / share (TTM)$2.60
5y CAGR+7.6%

Annual dividend per share

2021$2.58
2022$2.83
2023$3.05
2024$3.24
2025$3.40
2026$0.88

Federal Contracts

AmountAgencyDescription
$7.46MDepartment of DefenseSPD/HLD SUPPORT SERVICES
$3.64MDepartment of Veterans AffairsMAKO 4 ROBOTIC SYSTEM
$3.58MDepartment of Veterans AffairsSTRYKER BARIATRIC BEDS (MV3) AND MATTRESSES
$3.28MDepartment of Defense8510009272!FIXATION SET,EXTERN
$3.28MDepartment of Veterans AffairsSTRYKER BED PURCHASE FOR ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER
$3.24MDepartment of Veterans AffairsASHEVILLE VA OR LIGHTING SYSTEM
$3.06MDepartment of Veterans AffairsANKLE SETS
$2.86MDepartment of Veterans AffairsLIFEPAK DEFIBRILLATORS

SEC Filings

DateFormDoc
2026-08-044view
2026-08-044view
2026-08-044view
2026-08-044view
2026-07-3110-Qview
2026-07-308-Kview
2026-06-268-Kview
2026-06-024view
2026-05-294view
2026-05-284view
2026-05-208-Kview
2026-05-124view
2026-05-1110-Qview
2026-05-084view
2026-05-084view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$25.12B+8.6%
Gross profit$3.33B-1.3%
Operating income$4.89B+7.3%
Net income$654.00M-2.7%
Cash from ops$5.04B+9.5%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$269.93$275.84$268.69$272.362.34M
Sep 24$273.22$275.71$269.73$269.752.29M
Sep 23$274.46$277.10$271.45$273.402.72M
Sep 22$277.00$278.99$274.99$275.092.36M
Sep 21$274.58$276.87$272.00$274.192.76M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →